Eton Pharmaceutcials Inc (ETON) financials
Eton Pharmaceutcials revenue and earnings by year
Eton Pharmaceutcials's revenue was $80.8 million in the fiscal year to December 31, 2025, up 105.6% from the year before. Net income was -$4.60 million, -5.7% of revenue. Since the fiscal year to December 31, 2019, revenue has grown 109.3% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 7 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 81 | 39 | 33 | 23 | 23 | 0 | 1 |
| Revenue growth | 105.6% | 20.3% | 42.6% | -1.9% | 59725.6% | -95.9% | — |
| Gross profit | 44 | 24 | 22 | 16 | 21 | -0 | 1 |
| Gross margin | 53.9% | 60.3% | 67.6% | 69.7% | 87.9% | -1017.9% | 52.8% |
| Operating income | -0 | -2 | -0 | -7 | 0 | -27 | -19 |
| Operating margin | -0.0% | -5.9% | -0.6% | -28.9% | 0.0% | -69515.4% | -1939.6% |
| Net income | -5 | -4 | -1 | -9 | -2 | -28 | -18 |
| Net margin | -5.7% | -9.7% | -2.9% | -39.4% | -8.4% | -71717.9% | -1910.3% |
| Diluted EPS | -$0.17 | -$0.15 | -$0.04 | -$0.36 | -$0.08 | -$1.36 | -$1.03 |
| Free cash flow | 10 | 1 | 7 | 5 | -5 | -22 | -19 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ETON in Markets.
See also: ETON valuation and P/E history · ETON returns
No forecast, no recommendation. This page describes Eton Pharmaceutcials Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.